Understanding how a specific immune response helps fight Legionella infections
THE ROLE OF THE NON-CANONICAL INFLAMMASOME IN INNATE IMMUNITY
This study is looking at how a part of our immune system called caspase-11 helps fight off infections from a germ that can make people very sick, especially those who are older or have cancer, to find new ways to improve their treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-11078305 on NIH RePORTER |
What this research studies
This research investigates the role of a specific component of the immune system, known as caspase-11, in fighting infections caused by the bacterium Legionella pneumophila, which can lead to serious illness in vulnerable populations. The study focuses on how caspase-11 helps immune cells called macrophages clear the infection by using advanced imaging techniques and molecular analyses to understand the underlying mechanisms. By examining how this immune response works, the research aims to identify potential new targets for improving treatment in patients with weakened immune systems, such as the elderly and cancer patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include elderly individuals and cancer patients who are immunocompromised and at risk for Legionella infections.
Not a fit: Patients with strong immune systems who are not at risk for Legionella infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for patients at high risk of Legionella infections, potentially reducing morbidity and mortality.
How similar studies have performed: Previous research has shown that understanding immune responses can lead to significant advancements in treating infectious diseases, suggesting that this approach has potential for success.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Amer, Amal O — Ohio State University
- Study coordinator: Amer, Amal O
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.